<DOC>
	<DOCNO>NCT00628173</DOCNO>
	<brief_summary>Purpose : To compare efficacy safety Ahmed Glaucoma Valve ( AGV ) implantation superior versus inferior quadrant . Methods : In non-randomized clinical trial period two year , consecutive patient refractory glaucoma underwent AGV implantation superior inferior quadrant . Main outcome measure include best correct visual acuity ( BCVA ) , intraocular pressure ( IOP ) , number glaucoma medication , complication success rate ( define least 30 % IOP reduction preoperative value 5 &lt; IOP &lt; 22 mmHg without glaucoma medication ) . Other criteria failure include implant removal , additional glaucoma surgery , phthisis bulbi loss light perception .</brief_summary>
	<brief_title>Results Different Location Ahmed Glaucoma Valve Implantation Refractory Glaucoma , Superior Versus Inferior</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Patients refractory glaucoma need AGV implantation Eyes le 3 month followup Severe conjunctival adhesion scar site surgery Presence thin sclera staphyloma site surgery The presence anticipate need silicone oil superior implantation Active neovascular glaucoma inferior implantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>